Sustained long-term benefit of patent foramen ovale closure on migraine

Catheterization and Cardiovascular Interventions

Volumn 77, Issue 4, 2011, Pages 570-574

  Trabattoni, Daniela ^a   Fabbiocchi, Franco ^a   Montorsi, Piero ^a   Galli, Stefano ^a   Teruzzi, Giovanni ^a   Grancini, Luca ^a   Gatto, Pamela ^a   Bartorelli, Antonio L ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Migraine; Patent foramen ovale; Percutaneous PFO closure

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BRAIN ISCHEMIA; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; FALSE ANEURYSM; FEMALE; FOLLOW UP; HEART ANEURYSM; HEART ATRIUM FIBRILLATION; HEART ATRIUM SEPTUM; HEART CATHETERIZATION; HEART RIGHT LEFT SHUNT; HEMATOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; PATENT FORAMEN OVALE; PATENT FORAMEN OVALE CLOSURE; RECURRENCE RISK; RECURRENT DISEASE; RISK REDUCTION; SEPTAL OCCLUDER; THERAPY EFFECT; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADULT; CEREBROVASCULAR DISORDERS; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; FORAMEN OVALE, PATENT; HEART CATHETERIZATION; HUMANS; ITALY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; RECURRENCE; SEPTAL OCCLUDER DEVICE; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 79952235457     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22826     Document Type: Article

References (29)

1. Goadsby PJ, Lipton RB, Ferrari MD. Migraine: Current understanding and treatment. N Engl J Med 2002;346:257-270.
2. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias, and facial pain. Cephalalgia 1998;8(Suppl 7):1-96.
3. Launer LJ, Terwind GM, Ferrari MD. The prevalence and characteristics of migraine in a population-based cohort: The GEM study. Neurology 1999;53:537-542. (Pubitemid 29382048)
4. Domitrz I, Mieszkowski J, Kaminska A. Relationship between migraine and patent foramen ovale: A study of 121 patients with migraine. Headache 2007;47:1311-1318.
5. Sacher RA. Thrombophilia: A genetic predisposition to thrombosis. Trans Am Clin Climatol Assoc 1999;110:51-60.
6. Mugge A, Daniel WG, Angermann C, Spes C, Khandheria BK, Kronzon I, Freedberg RS, Keren A, Denning K, Engberding R, Sutherland GR, Vered Z, Erbel R, Visser CA, Lindert O, Hausman D, Wenzlaff P. Atrial septal aneurysm in adult patients. A multicenter study using transthoracic and transesophageal echocardiography. Circulation 1995;91:2785-2792.
7. Spencer MP. Detection of embolism with Doppler ultrasound: A review. Echocardiography 1996;13:519-528.
8. Del Sette M, Dinia L, Rizzi D, Sugo A, Albano B, Gandolfo C. Diagnosis of right-to-left shunt with transcranial Doppler and vertebrobasilar recording. Stroke 2007;38:2254-2256. (Pubitemid 47457564)
9. Anzola GP, Morandi E, Casilli F, Onorato E. Different degrees of right-to-left shunt predict migraine and stroke: Data from 420 patients. Neurology 2006;66:765-767. (Pubitemid 43739842)
10. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 2000;356:1648-1651.
11. Venketasubramanian N, Sacco RL, Di Tullio M, Sherman D.Homma S, Mohr JP. Vascular distribution of paradoxical emboli by transcranial Doppler. Neurology 1993;43.1533-1535.
12. Pierangeli G, Cevoli S, Zanigni S, Sancisi E, Monaldini C, Donti A, Ribani MA, Montagna P, Barbiroli B. The role of cardiac diseases in the comorbidity between migraine and stroke. Neurol Sci 2004;25(Suppl 3):S129-S131. (Pubitemid 41461976)
13. Schwerzmann M, Nedeltchev K, Lagger F, Mattle HP, Windecker S, Meier B, Seiler C. Prevalence and size of directly detected patent foramen ovale in migraine with aura. Neurology 2005;65:1415-1418.
14. Anzola GP, Magoni M, Guindani M, Rozzini L, Dalla Volta G. Potential source of cerebral embolism in migraine with aura: A transcranial Doppler study. Neurology 1999;52:1622-1625. (Pubitemid 29220637)
15. Giardini A, Donti A, Formigari R. Transcatheter patent foramen ovale closure mitigates aura migraine headaches abolishing spontaneous right-to-left shunting. Am Heart J 2006;151:922. e1-e5.
16. Rigatelli G, Braggion G, Aggio S, Chinaglia M, Cardaioli P. Primary patent foramen ovale closure to relieve severe migraine. Ann Intern Med 2006;144:458-459.
17. Jesurum JT, Fuller CJ, Kim CJ, Krabill KA, Spencer MP, Olsen JV, Likosky WH, Reisman M. Frequency of migraine headache relief following patent foramen ovale "closure" despite residual right-to-left shunt. Am J Cardiol 2008;102:916-920.
18. D'Amico D, Usai S, Caputi L, Bussone G. Does closure of a patent foramen ovale have a role in the treatment of migraine with aura? Neurol Sci 2008;29:S23-S27.
19. Chessa M, Colombo C, Butera G, Negura D, Piazza L, Varotto L, Bussadori C, Fesslova V, Meola G, Carminati M. Is it too early to recommend patent foramen ovale closure for all patients who suffer from migraine? A single-center study. J Cardiovasc Med 2009;10:401-405.
20. Dowson A, Mullen MJ, Peatfield R, Muir K, Khan AA, Wells C, Lipscombe SL, Ress T, De Giovanni JV, Morrison WL, Hildick-Smith D, Elrington G, Hillis WS, Malik IS, Rickards A. Migraine intervention with STARFlex Technology (MIST) trial: A prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 2008;117:1397-1404.
21. Sarens T, Herroelen L, Van Deyk K, Budts W. Patent foramen ovale and migraine: Are we following the wrong pathway? J Neurol 2009;256:143-144.
22. Van der Kuy PH, Lohman JJ. A quantification of the placebo response in migraine prophylaxis. Cephalalgia 2002;22:265-270. (Pubitemid 41701443)
23. Wilmshurst P, Nightingale S. The role of cardiac and pulmonary pathology in migraine: A hypothesis. Headache 2006;46:429-434.
24. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL. Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects. Heart 2005;91:1173-1175. (Pubitemid 41192391)
25. Sharifi M, Dehghani M, Mehdipour M, Al-Bustami O, Emrani F, Burks J. Intense migraines secondary to percutaneous closure of atrial septal defects. J Interv Cardiol 2005;18:181-183. (Pubitemid 40942729)
26. Rundek T, Elkind M, Di Tullio MR, Carrera E, Jin Z, Sacco RL, Homma S. Patent foramen ovale and migraine. A cross sectional study from the Northern Manhattan Study (NOMAS). Circulation 2008;118:1419-1424.
27. Morandi E, Anzola GP, Casilli F, Onorato E. Migraine: Traditional or "innovative" treatment? A preliminary case-control study. Pediatr Cardiol 2005;26:231-233.
28. Reisman M, Christofferson RD, Jesurum J. Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardiol 2005;45:493-495. (Pubitemid 40222239)
29. Schwerzmann M, Wiher S, Nedeltchev K. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology 2004;2:1399-1401.